OpenExamsFREE PRACTICE — ANY EXAM

Kansas Pharmacist — Requirements & Free Practice

US-KS · License preparation

850 free questions · Answer explanations · No signup required

Choose what to practice

Start with an exam below. Your examination requirements depend on your application pathway. View licensing requirements

Combined practice

Choose an exam or combined practice to begin.

Licenses, application pathways and examination requirements

Each license and applicant pathway has its own requirements and exemptions. Choosing practice questions does not determine your eligibility.

Pharmacist License

License to practice as a pharmacist in Kansas, issued by the Kansas State Board of Pharmacy under K.S.A. 65-1631.

Licensing authority: Kansas State Board of Pharmacy · Application information

Licensure by examination for a graduate of a school or college of pharmacy recognized and approved by the Board (Form LA 01E), including NAPLEX score transfer within 90 days

All of the following:

Age
At least 18 years of age (K.S.A. 65-1631(a)).
Application
Form LA-01E Pharmacist by Exam with a $157 fee ($100 with an active Kansas intern registration) and a KBI/FBI fingerprint background check; the Board must approve the application before NABP issues the Authorization to Test.
Education
Graduate of a school or college of pharmacy recognized and approved by the Board: an ACPE-accredited program, or one the Board finds has a standard of education not below that of the University of Kansas School of Pharmacy (K.S.A. 65-1631(a); K.A.R. 68-1-1d).
Jurisprudence Examination
Pass either the UMPJE together with the Kansas Plus Module, or the Kansas MPJE. The Kansas MPJE is an alternative only while it is offered: NABP lists its Kansas retirement date as March 31, 2027, and the Board UMPJE page states "The Kansas MPJE will no longer be offered or required as of April 1, 2027." The Board January 2026 newsletter had said the Kansas MPJE may be elected "until it is discontinued at the end of 2026."
Kansas Plus Module Exemption
Graduates of the University of Kansas School of Pharmacy are exempt from the Kansas Plus Module (Board Pharmacists page; Form LA-01E).
Military Fee Waiver
Active-duty military or military spouses residing or planning to reside in Kansas on military orders may be exempt from the background check, initial and renewal application fees (Form LA-01E).
Naplex Score Transfer
The same application covers individuals who passed the NAPLEX in the past 90 days and had the score transferred to Kansas.
Newsletter Statement
The Board January 2026 newsletter states that new graduates "will be required to pass both the North American Pharmacist Licensure Examination® and the Uniform MPJE™" without mentioning the Kansas Plus Module; the Board UMPJE page and Form LA-01E require the module of UMPJE candidates.
Passing Score
The Board accepts a passing score on an examination required for licensure only from the first five attempts (K.S.A. 65-1631(c)); K.A.R. 68-1-2 requires a grade of not less than 75% on the law examination administered by the Board.
Pharmaceutical Experience
One year of pharmaceutical experience under a preceptor, i.e. 1,740 clock-hours as a pharmacy student or registered intern (K.S.A. 65-1631(a); K.A.R. 68-1-3a). Form LA-01E states this proof is not required for graduates of KU or UMKC.
Licensure by examination for a foreign pharmacy graduate holding FPGEC Certification (Form LA 01E)

All of the following:

Application
Form LA-01E Pharmacist by Exam with fee and KBI/FBI fingerprint background check.
English Proficiency
TOEFL iBT minimum scores of 22 reading, 21 listening, 26 speaking and 24 writing (K.S.A. 65-1631(i); K.A.R. 68-1-1f).
Evaluation Fee
Applicants who graduated outside the United States or from a school not approved by the Board submit information specified by rule with an evaluation fee (K.S.A. 65-1631(h)).
Foreign Graduate
Undergraduate pharmacy degree conferred by a recognized school of pharmacy outside the 50 states, the District of Columbia and Puerto Rico (other than the Lebanese American University School of Pharmacy), including Canadian schools (Foreign Pharmacy Graduate instructions).
Fpgec Certification
FPGEC Certification from NABP, obtained by passing the FPGEE with a score of at least 75 and the TOEFL iBT, and a copy of the certificate submitted to the Board (K.A.R. 68-1-1h; instructions).
Internship
After FPGEC Certification, Kansas intern registration (Form LA-03) and 1,740 intern hours under a Kansas-licensed pharmacist (K.A.R. 68-1-3a; instructions).
Jurisprudence Examination
Pass either the UMPJE together with the Kansas Plus Module, or the Kansas MPJE. The Kansas MPJE is an alternative only while it is offered: NABP lists its Kansas retirement date as March 31, 2027, and the Board UMPJE page states "The Kansas MPJE will no longer be offered or required as of April 1, 2027." The Board January 2026 newsletter had said the Kansas MPJE may be elected "until it is discontinued at the end of 2026."
Passing Score
The Board accepts a passing score on an examination required for licensure only from the first five attempts (K.S.A. 65-1631(c)); K.A.R. 68-1-2 requires a grade of not less than 75% on the law examination administered by the Board.
Renewal on inactive status by a pharmacist who has not met the continuing education requirement
No examination is required for this applicant pathway.
Inactive Status
Renewal fee paid without the continuing education requirement; an inactive status licensee may not practice pharmacy in Kansas (K.S.A. 65-1632(e)).

Official no-examination sources

Effective from 2014-07-01.

Cancellation of inactive status and return to active licensure
No examination is required for this applicant pathway.
Reactivation
Evidence of compliance with the continuing education requirements (not more than 60 hours) and payment of all applicable fees (K.S.A. 65-1632(d), (e)).

Official no-examination sources

Effective from 2014-07-01.

Licensure by reciprocity / license transfer for a pharmacist licensed by examination in another state (Form LA 01R and NABP Electronic Licensure Transfer Program)

At least one of the following alternatives:

  • All of the following:

  • Kansas Multistate Pharmacy Jurisprudence Examination (practice unavailable)
Competency Examination
An applicant not subject to continuing-education laws for renewal in the other state must satisfy the Board through a competency examination that the applicant meets Kansas standards (K.S.A. 65-1631(e)); no official source identifies that examination.
Education And Training
Proof of the education and training required of Kansas applicants, judged by the requirements in force when the applicant was licensed in the other state; reciprocity is not denied to an applicant who met that state's internship requirements or has at least one year of practice as a licensed pharmacist (K.S.A. 65-1631(d); K.A.R. 68-1-3a(d)).
Jurisprudence Examination
Pass either the UMPJE together with the Kansas Plus Module, or the Kansas MPJE. The Kansas MPJE is an alternative only while it is offered: NABP lists its Kansas retirement date as March 31, 2027, and the Board UMPJE page states "The Kansas MPJE will no longer be offered or required as of April 1, 2027." The Board January 2026 newsletter had said the Kansas MPJE may be elected "until it is discontinued at the end of 2026."
License Transfer
Submit Form LA-01R ($182; $125 with an active Kansas intern registration) and, after passing the jurisprudence examination, the NABP Electronic Licensure Transfer Program application; KBI/FBI fingerprint background check.
Licensed Elsewhere
Registered or licensed as a pharmacist by examination in another state; the Board page directs pharmacists licensed in another state for more than 90 days who did not transfer their NAPLEX score to this application (K.S.A. 65-1631(d); Pharmacists page).
Military Fee Waiver
Active-duty military or military spouses residing or planning to reside in Kansas on military orders may be exempt from the background check, initial and renewal application fees (Form LA-01R).
Newsletter Statement
The Board January 2026 newsletter states that license transfer applicants "will be required to pass the Uniform MPJE™" without mentioning the Kansas Plus Module; the Board Pharmacists page, UMPJE page and Form LA-01R (revised 08/2026) require "the UMPJE plus the Kansas Module".
Passing Score
The Board accepts a passing score only from the first five attempts (K.S.A. 65-1631(d)); K.A.R. 68-1-2(b) requires not less than 75% on the law examination administered by the Board.
Reciprocity
Applies only if the other state grants, under like conditions, reciprocal licensure without examination to Kansas pharmacists; the Board licenses in its discretion (K.S.A. 65-1631(d)).
Reinstatement of a license that lapsed for nonpayment of the renewal fee for less than three consecutive years
No examination is required for this applicant pathway.
Reinstatement
Payment of the unpaid renewal fee plus the penalty fee and proof of compliance with the continuing education requirements (K.S.A. 65-1632(f)); an examination applies only after three consecutive years or more of nonrenewal (K.A.R. 68-1-7).

Official no-examination sources

Effective from 2014-07-01.

Biennial renewal of an active pharmacist license
No examination is required for this applicant pathway.
Continuing Education
30 clock-hours of Board-approved continuing education per licensure period, including the one-hour course provided by the Board (K.S.A. 65-1632(d); K.A.R. 68-1-1b).
Renewal
Renewal fee and application by the June 30 expiration date of the renewal year; licenses renew every two years.

Official no-examination sources

Effective from 2014-07-01.

Foreign Pharmacy Graduate Equivalency Examination

Provider
National Association of Boards of Pharmacy
Format
Computerized fixed form
Exam questions
200 questions
Time limit
4.5 hours examination time; 5.5 hours total seat time
Passing score
Scaled score of 75
Examination outline
  • Foundational Biomedical Sciences (12%)
    • Anatomy and physiology
    • Biochemistry
    • Medical microbiology
    • Immunology
    • Pathophysiological bases of diseases
  • Pharmaceutical Sciences (31%)
    • Pharmaceutical calculations (eg, dose adjustments, delivery, ionization, ionic strength, isotonicity, ratio/percentage strength, osmolarity)
    • Medicinal chemistry
    • Medicinal chemistry: Physicochemical properties of drugs in relation to drug absorption, distribution, metabolism, and excretion (ADME)
    • Medicinal chemistry: Pathways of drug metabolism
    • Medicinal chemistry: Chemical bases for drug action, including bioorganic chemistry, structure-activity relationships, and fundamental pharmacophores related to drug-receptor interactions
    • Medicinal chemistry: Applicability to making drug therapy decisions
    • Pharmacology and toxicology
    • Pharmacology and toxicology: Pharmacodynamics, including drug-receptor interactions, agonists, antagonists, inverse agonists, and dose-response curves
    • Pharmacology and toxicology: Mechanisms of action of drugs, including biologics
    • Pharmacology and toxicology: Adverse effects and side effects of drugs
    • Pharmacology and toxicology: Mechanisms of drug interactions, including drug-drug, drug-disease, drug-food, drug-allergy, and drug-laboratory interactions
    • Pharmacology and toxicology: Mechanisms of acute and chronic toxic effects of xenobiotics, including drug and chemical overdose or exposure and antidotes
    • Pharmaceutics and biopharmaceutics
    • Pharmaceutics and biopharmaceutics: Dosage form development and drug delivery systems such as immediate release, sustained release, and controlled release
    • Pharmaceutics and biopharmaceutics: Disintegration and dissolution of solid oral dosage forms
    • Pharmaceutics and biopharmaceutics: Physicochemical properties of drugs, excipients, solutions, and dosage forms
    • Pharmaceutics and biopharmaceutics: Physical stability, chemical stability, and shelf-lives, including zero-, first-, second-, and pseudo-order reactions
    • Pharmaceutics and biopharmaceutics: Interactions between drug formulation and biological effects
    • Pharmaceutics and biopharmaceutics: Drug product manufacturing, including methods, processing, and quality assurance
    • Pharmacokinetics
    • Pharmacokinetics: Determining rates of absorption, distribution, metabolism, and excretion (ADME) of drugs
    • Pharmacokinetics: Factors affecting rates of ADME, including age, sex, genetics, diet, disease, and drug interactions
    • Pharmacokinetics: Biological half-lives of drugs and related dosing
    • Pharmacokinetics: Compartment models (one-, two-, and non-)
    • Pharmacokinetics: Linear and nonlinear pharmacokinetics
    • Pharmacokinetics: Principles of bioavailability, bioequivalence, and biosimilars
    • Pharmacogenomics (eg, population-based genetic influences on drug metabolism and efficacy, genetic testing, tumor genotyping, pharmacogenetic screening)
    • Extemporaneous compounding (eg, United States Pharmacopeia (USP) standards including Chapters <795>, <797>, and <800>; dosage form preparation calculations; techniques used to prepare and dispense sterile and nonsterile preparations)
  • Social, Behavioral, and Administrative Sciences (20%)
    • Pharmacy law and ethics
    • Pharmacy law and ethics: Laws and regulations governing pharmacy
    • Pharmacy law and ethics: Regulatory, oversight, and professional organizations
    • Pharmacy law and ethics: Principles and application of biomedical ethics
    • Health care systems
    • Health care systems: Organization, regulation, and financing of health care delivery in the United States
    • Health care systems: Factors that influence delivery and use of health care (eg, social, political, economic, and technological)
    • Pharmacoeconomics (eg, analysis, interpretation, application, humanistic outcomes)
    • Population-based care, pharmacoepidemiology, and public health
    • Population-based care, pharmacoepidemiology, and public health: Data sources and analytic tools
    • Population-based care, pharmacoepidemiology, and public health: Application of epidemiological study design
    • Population-based care, pharmacoepidemiology, and public health: Health promotion, disease prevention, and infection control
    • Population-based care, pharmacoepidemiology, and public health: Continuous quality improvement
    • Population-based care, pharmacoepidemiology, and public health: Social determinants and drivers of health
    • Practice management
    • Practice management: Financial management and budgeting
    • Practice management: Personnel management
    • Practice management: Business and strategic planning
    • Practice management: Risk management
    • Practice management: Procurement and inventory control
    • Professional communication
    • Professional communication: Verbal, nonverbal, written, and technology-based communication with patients, caregivers, providers, and stakeholders
    • Professional communication: Health literacy
    • Biostatistics and research methods (eg, study design, statistical tests, data collection instruments, research ethics)
    • Social and behavioral aspects of practice
    • Social and behavioral aspects of practice: Patient behavior including health-, illness-, and sick-role
    • Social and behavioral aspects of practice: Principles of behavior modification
    • Social and behavioral aspects of practice: Patient adherence
    • Social and behavioral aspects of practice: Cultural awareness
  • Pharmacy Practice and Clinical Sciences (37%)
    • Clinical pathophysiology as it applies to treatment of disease processes
    • Data collection (eg, patient history, physical assessments, laboratory values, point-of-care testing)
    • Data assessment (eg, clinical calculations, interpretation of data, diagnosing)
    • Patient-care decision making, therapy recommendations, and education (eg, plan, implement, monitor, follow-up)
    • Patient safety (eg, drug interactions, toxicity, drug-induced disease, drug use disorders)
    • Disease prevention (eg, screenings, immunization, non-pharmacological therapies, lifestyle modifications)
    • Personalized medicine (eg, pharmacokinetics, pharmacogenetics)
    • Evidence-based practice
    • Evidence-based practice: Practice guidelines
    • Evidence-based practice: Drug information and evaluation
    • Evidence-based practice: Information source reliability
    • Evidence-based practice: Clinical trial evaluation
    • Self-care, including using natural products
Examination sources

Kansas Multistate Pharmacy Jurisprudence Examination

Provider
National Association of Boards of Pharmacy (delivered by Pearson VUE)
Format
Fixed-length computer adaptive test; multiple-choice and multiple-response items
Exam questions
100 operational (scored) items and 20 pretest (unscored) items
Examination outline
  • Area 1 — Licensure/Personnel (22%)
    • 1.1 – Responsibilities of the pharmacist and non-pharmacist personnel: qualifications, scope of duties, limitations, and restrictions of duties, or conditions to practice for pharmacists-in-charge (or equivalent) and pharmacists; the same for non-pharmacist personnel
    • 1.2 – Licensures, registrations, and certifications for pharmacists or non-pharmacist personnel: qualifications, examinations, internships, maintaining pharmacist competency, and renewals of licensures, registrations, or certifications; classifications and processes of disciplinary actions; reporting to and participating in programs addressing the inability to practice with reasonable skill and safety
  • Area 2 — Pharmacist Practice (33%)
    • 2.1 – Requirements for issuing prescriptions/drug orders: requirements for drug uses, limitations, or restrictions; scope of authority, scope of practice, limitations or restrictions of practice, and valid registration of practitioners who are authorized to prescribe, dispense, or administer drugs; requirements for issuing non-controlled prescriptions/drug orders; requirements for issuing controlled prescriptions/drug orders; authority limitations of practitioners’ ability to authorize refills
    • 2.2 – Conditions under which the pharmacist or non-pharmacist personnel participates in the administration of drugs in the management of patients’ therapy
    • 2.3 – Requirements regarding counseling: counseling or offering to counsel; documenting counseling or documenting offering to counsel
    • 2.4 – Returning or reusing drugs
    • 2.5 – Regulations and agencies regarding pharmacy practice: requirements for promoting quality and safety of public health; protecting patient and health record confidentiality
  • Area 3 — Dispensing Requirements (24%)
    • 3.1 – Responsibilities for determining whether prescriptions/drug orders are issued for a legitimate medical purpose, and within all applicable restrictions
    • 3.2 – Transferring prescription/drug order information between pharmacies by authorized personnel
    • 3.3 – Prospective drug utilization reviews: requirements for reporting to PMP and accessing PMP data
    • 3.4 – Exceptions to dispensing or refilling prescriptions/drug orders
    • 3.5 – Labeling of dispensed drugs
    • 3.6 – Packaging of dispensed drugs
    • 3.7 – Drug product conditions prohibiting dispensing
    • 3.8 – Requirements for the distribution and/or dispensing of non-prescription pharmaceutical products, including controlled substances and hazardous drugs: dispensing or administration; labeling of non-prescription drugs and devices; packaging and repackaging of non-prescription drugs and behind-the-counter products; dispensing-restricted, non-prescription drugs
  • Area 4 — Pharmacy Operations (21%)
    • 4.1 – Ordering, acquisition, and distribution of drugs, including maintenance and content of such records: ordering and acquisition, including the maintenance and content of such records; distribution, including the maintenance and content of such records
    • 4.2 – Recordkeeping in compliance with legal requirements, including content, inventory, maintenance, storage, handling, and reporting: non-dispensing requirements for operations of pharmacies or practice settings; possession, storage, and handling of non-hazardous drugs; training, possession, handling, storage, and disposal of hazardous drugs; allowing non-pharmacist personnel access to drugs; requirements for conducting controlled substance inventories
    • 4.3 – Delivery of drugs
    • 4.4 – Conditions for permitted or mandated product selection
    • 4.5 – Compounding sterile, nonsterile, hazardous, and non-hazardous preparations
    • 4.6 – Centralized prescription processing or central-fill pharmacy dispensing
    • 4.7 – Requirements for the registration, licensure, certification, or permitting of a practice setting or business entity: requirements for registration, license, certification, or permitting of a practice setting; requirements for the renewal or reinstatement of a license, registration, certificate, or permit of a practice setting; requirements for an inspection of a licensed, registered, certified, or permitted practice setting; classifications and processes of disciplinary actions that may be taken against a registered, licensed, certified, or permitted practice setting
Examination sources

Kansas Plus Module

Provider
Kansas State Board of Pharmacy (online module)
Passing score
At least 20 questions correct
Examination outline
  • Kansas Statutes Annotated, Chapter 65, Article 16 — Regulation of Pharmacists (Pharmacy Act of the State of Kansas and related acts)
  • Kansas Administrative Regulations, Agency 68, Article 1 — Registration and Examination of Pharmacists
  • Kansas Administrative Regulations, Agency 68, Article 2 — Drugstores
  • Kansas Administrative Regulations, Agency 68, Article 3 — Retail Dealers Permit
  • Kansas Administrative Regulations, Agency 68, Article 5 — General Rules
  • Kansas Administrative Regulations, Agency 68, Article 7 — Miscellaneous Provisions
  • Kansas Administrative Regulations, Agency 68, Article 8 — Advertising
  • Kansas Administrative Regulations, Agency 68, Article 9 — Automated Prescription Systems
  • Kansas Administrative Regulations, Agency 68, Article 11 — Fees
  • Kansas Administrative Regulations, Agency 68, Article 12 — Resale of Medication
  • Kansas Administrative Regulations, Agency 68, Article 13 — Compounding Sterile and Nonsterile Preparations
  • Kansas Administrative Regulations, Agency 68, Article 14 — Wholesale Distributors
  • Kansas Administrative Regulations, Agency 68, Article 15 — Nonprescription Wholesale Distributors
  • Kansas Administrative Regulations, Agency 68, Article 18 — Utilization of Unused Medications
  • Kansas Administrative Regulations, Agency 68, Article 19 — Continuous Quality Assurance Programs
  • Kansas Administrative Regulations, Agency 68, Article 20 — Controlled Substances
  • Kansas Administrative Regulations, Agency 68, Article 21 — Prescription Monitoring Program
  • Kansas Administrative Regulations, Agency 68, Article 22 — Electronic Supervision of Medical Care Facility’s Pharmacy Personnel
  • Kansas Statutes Annotated, Chapter 65, Article 41 — Controlled Substances (Uniform Controlled Substances Act)
  • Kansas Statutes Annotated, Chapter 65, Article 6 — Food, Drugs and Cosmetics (Kansas Food, Drug, and Cosmetic Act and related sections, as enumerated)
  • Kansas Statutes Annotated, Chapter 65, Article 70 — Chemical Control (Kansas Chemical Control Act)
  • Kansas Statutes Annotated, Chapter 21, Article 57 — Crimes Involving Controlled Substances
  • Kansas Statutes Annotated, animal vaccine sales (selected statutes)
  • Kansas Statutes Annotated, epinephrine kits in schools (selected statute)
  • Kansas Statutes Annotated, Chapter 65, Article 4 — medical care facilities, termination of pregnancy (selected statutes)
  • Kansas Statutes Annotated, Chapter 65, Article 49 — health care providers and contact lens prescriptions (selected statutes)
  • Kansas Statutes Annotated, social welfare drug formulary (selected statute)
  • Kansas Administrative Regulations, Agency 28, Article 39 — licensure of adult care homes, pharmacy services (selected regulation)
  • Kansas Administrative Regulations, Agency 28, Article 34 — hospital pharmacy services (selected regulation)
  • Kansas Statutes Annotated, emergency medical services, automated external defibrillators (selected statute)
  • Kansas Statutes Annotated, Kansas retailers' sales tax, exempt sales (selected statute)
  • Kansas Statutes Annotated, Chapter 40, Article 38 — pharmacy benefits managers (selected statutes)
  • Kansas Statutes Annotated, Chapter 40, Article 34 — health care provider insurance (selected statutes)
  • Kansas Statutes Annotated, transient merchant licensing act, flea markets (selected statute)
  • Kansas Statutes Annotated, jurors, exclusions from jury service (selected statute)
  • Kansas Statutes Annotated, healing arts (selected statutes)
Examination sources

North American Pharmacist Licensure Examination

Provider
National Association of Boards of Pharmacy
Format
Computerized fixed form
Exam questions
225 questions
Time limit
6 hours
Passing score
Pass or Fail
Examination outline
  • Foundational Knowledge for Pharmacy Practice (25%)
    • Pharmaceutical science principles and concepts
    • Pharmaceutical science principles and concepts: Pharmacology
    • Pharmaceutical science principles and concepts: Pharmacokinetics, pharmacodynamics, or pharmacogenomics
    • Pharmaceutical science principles and concepts: Pharmaceutics
    • Pharmaceutical compounding
    • Pharmaceutical compounding: Nonsterile preparations
    • Pharmaceutical compounding: Sterile preparations
    • Pharmaceutical calculations
    • Pharmaceutical calculations: Patient parameters or laboratory measures
    • Pharmaceutical calculations: Quantities of drugs to be dispensed or administered
    • Pharmaceutical calculations: Rates of administration
    • Pharmaceutical calculations: Dose conversions
    • Pharmaceutical calculations: Drug concentrations, ratio strengths, osmolarity, or osmolality
    • Pharmaceutical calculations: Quantities of drugs or ingredients to be compounded
    • Pharmaceutical calculations: Nutritional needs and the content of nutrient sources
    • Pharmaceutical calculations: Biostatistical, epidemiological, or pharmacoeconomic measures
    • Pharmaceutical calculations: Pharmacokinetic parameters
    • Drug development processes (eg, clinical trial phases, emergency use authorizations)
    • Research design principles and biostatistics (eg, blinding, randomization, biases, statistical tests and outcomes, ethics)
    • Retrieval, assessment, and interpretation of primary, secondary, and tertiary resources
  • Medication Use Process (Prescribing, Transcribing and Documenting, Dispensing, Administering, and Monitoring) (25%)
    • Prescriptions and medication order interpretation
    • Prescriptions and medication order interpretation: Drug names and therapeutic classes
    • Prescriptions and medication order interpretation: Indications, usage, and dosing regimens
    • Prescriptions and medication order interpretation: Available dosage forms
    • Prescriptions and medication order interpretation: Prescription regulations (eg, boxed warnings, risk evaluation and mitigation strategies)
    • Prescriptions and medication order interpretation: Safety and effectiveness (eg, laboratory parameters, vital signs)
    • Therapeutic substitutions (eg, formulary restrictions, therapeutic alternatives, shortages, biosimilars)
    • Immunization services and documentation
    • Immunization services and documentation: Indications and scheduling
    • Immunization services and documentation: Contraindications and precautions
    • Immunization services and documentation: Storage and handling
    • Immunization services and documentation: Administration (eg, techniques, preparation, routes)
    • Immunization services and documentation: Adverse reactions
    • Medication handling, storage, stability, and disposal (eg, hazardous and nonhazardous drugs, controlled substances, parenteral medications, sharps handling, temperature control)
  • Person-Centered Assessment and Treatment Planning (40%)
    • Medication history, allergy history, and reconciliation
    • Health histories, screenings, and assessments
    • Patient health conditions, including special populations and medication-related factors
    • Patient health conditions, including special populations and medication-related factors: Signs, symptoms, and findings of medical conditions, etiology of diseases, or pathophysiology
    • Patient health conditions, including special populations and medication-related factors: Appropriateness of therapy (eg, medications, immunizations, non-drug therapy, dosing, contraindications, warnings, evidence-based decision making)
    • Patient health conditions, including special populations and medication-related factors: Interactions (eg, drug-drug, drug-condition, drug-food, drug-allergy, drug-laboratory)
    • Patient health conditions, including special populations and medication-related factors: Errors and omissions (eg, dosing, duplication, additional therapy needed, unnecessary therapy)
    • Patient health conditions, including special populations and medication-related factors: Adverse drug reactions
    • Patient health conditions, including special populations and medication-related factors: Toxicologic exposures and overdoses
    • Patient health conditions, including special populations and medication-related factors: Adherence
    • Therapeutic monitoring, plan development, evaluation, and modifications
    • Therapeutic monitoring, plan development, evaluation, and modifications: Therapeutic goals, clinical endpoints, and follow-up
    • Therapeutic monitoring, plan development, evaluation, and modifications: Safety
    • Therapeutic monitoring, plan development, evaluation, and modifications: Effectiveness
    • Patient education
    • Patient education: Lifestyle modifications and health maintenance
    • Patient education: Medication use, storage, and disposal
    • Patient education: Disease state management
    • Over-the-counter medications and dietary supplements
    • Devices to administer medications and self-monitoring tests
  • Professional Practice (5%)
    • Adverse drug event reporting and medication error reporting (eg, MedWatch, VAERS)
    • Public health initiatives and risk-prevention programs (eg, tobacco and nicotine cessation, antimicrobial stewardship, health screenings, opioid stewardship)
    • Social determinants and drivers of health
    • Ethical considerations (eg, informed consent, ethical principles, professional conduct and responsibility, patient confidentiality)
  • Pharmacy Management and Leadership (5%)
    • Pharmacy operations (eg, operational planning, risk management, regulations and regulatory bodies, technology applications and informatics, error-prevention strategies, medication safety)
    • Inventory and supply management (eg, drug recalls, drug shortages)
    • Quality improvement activities (eg, medication use evaluation, root-cause analysis, continuous quality improvement)
    • Mentorship and preceptorship (eg, providing and receiving feedback, delegation of work activities, preceptor roles)
Examination sources

Uniform MPJE

Provider
National Association of Boards of Pharmacy
Format
Computer-based adaptive selected-response examination
Exam questions
120 questions
Time limit
2.5 hours
Passing score
Pass or Fail
Examination outline
  • Pharmacy and Pharmacist Practice (30%)
    • Practice of pharmacy definition (eg, scope of authority, scope of practice, collaborative practice agreements and other delegative authorities, limitations or restrictions on practice)
    • Non-pharmacist personnel (eg, supervision, scope, licensure, counseling)
    • Adulterated or misbranded medications (eg, medication recalls, expiration dates, counterfeit medications, emergency use authorizations, importation, Drug Supply Chain Security Act (DSCSA))
    • Federal regulatory standards (eg, National Institute for Occupational Safety and Health (NIOSH), Occupational Safety and Health Administration (OSHA), essential copies of commercial products, patient-specific prescription requirements, anticipatory compounding)
    • United States Pharmacopeia (USP) standards on compounding and hazardous materials (eg, beyond-use dating, competency training, environmental testing, record keeping)
    • Security of patient health information
  • Medication Use Process (Prescribing, Transcribing and Documenting, Dispensing, Administering, and Monitoring) (30%)
    • Requirements for issuing prescriptions and medication orders, including controlled substances
    • Requirements for issuing prescriptions and medication orders, including controlled substances: Validity of a prescription (eg, authority, content, corresponding responsibility)
    • Requirements for issuing prescriptions and medication orders, including controlled substances: Changes to a prescription
    • Requirements for issuing prescriptions and medication orders, including controlled substances: Emergency prescriptions and emergency refills
    • Dispensing medications, including controlled substances
    • Dispensing medications, including controlled substances: Pharmacy and manufacturer labeling, including over-the-counter medications and patient education
    • Dispensing medications, including controlled substances: Drug utilization review
    • Dispensing medications, including controlled substances: Fills, refills, and partial fills
    • Dispensing medications, including controlled substances: Packaging and repackaging
    • Dispensing medications, including controlled substances: Counseling
    • Dispensing medications, including controlled substances: Transfers
    • Dispensing medications, including controlled substances: Prescription drug monitoring program (PDMP) requirements
    • Dispensing medications, including controlled substances: Recalls, returns, and reuse
    • Dispensing medications, including controlled substances: Drug product selection (eg, substitutions, interchangeability)
    • Administration of medications, including adverse event reporting
  • Regulatory Authority and Legal Obligations (20%)
    • Role of regulatory authorities, including authority, inspections, and discipline
    • Role of regulatory authorities, including authority, inspections, and discipline: Federal (eg, Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), US Department of Health and Human Services (HHS))
    • Role of regulatory authorities, including authority, inspections, and discipline: State (eg, board of pharmacy, department of health)
    • Controlled substances
    • Controlled substances: Inventory
    • Controlled substances: Record keeping
    • Controlled substances: Order forms and ordering
    • Controlled substances: DEA registration and power of attorney
    • Controlled substances: Theft and loss
    • Controlled substances: Disposal
    • Liability and malpractice
  • Pharmacy Operations (20%)
    • Licensures, registrations, and certifications
    • Pharmacy technology, including record keeping and automation (eg, e-prescribing, faxing, shared services)
    • Access, storage, handling, and security
Examination sources